Antiretroviral Therapy Does Not Block the Secretion of the Human Immunodeficiency Virus Tat Protein

ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)

Volume 17, 3 Issues, 2017

Download PDF Flyer

Infectious Disorders - Drug Targets

Formerly: Current Drug Targets - Infectious Disorders

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Antiretroviral Therapy Does Not Block the Secretion of the Human Immunodeficiency Virus Tat Protein

Infectious Disorders - Drug Targets, 12(1): 81-86.

Author(s): Sonia Mediouni, Albert Darque, Gilbert Baillat, Isabelle Ravaux, Catherine Dhiver, Herve Tissot-Dupont, Malika Mokhtari, Herve Moreau, Catherine Tamalet, Corinne Brunet, Pascale Paul, Francoise Dignat-George, Andreas Stein, Philippe Brouqui, Stephen A. Spector, Grant R. Campbell and Erwann P Loret.

Affiliation: Equipe de Recherche Technologique 2011, Faculty of Pharmacy, University of the Mediterranean, 27 boulevard Jean Moulin, 13385 Marseille cedex 5, France.


Tat is a viral protein secreted from HIV infected cells and extra cellular Tat is suspected to prevent destruction of HIV infected cells from cells of the cellular immunity. The effect of anti retroviral therapy (ART) on Tat secretion has never been investigated. In this study, we tested for antibody reactivity against Tat variants representative of the main HIV subtypes in HIV positive patients receiving ART with undetectable viral loads ( < 40 copies/mL) over the course of one year with a blood sampling every three months. For each of theses five blood sampling, an average of 50 % of patients had Anti-Tat IgG, it turned out that 86% of patients could recognize Tat at least in one blood sampling during the course of the study. Amazingly, anti-Tat IgG appeared and/or disappeared in 66 % of patients. Only 20% had anti-Tat IgG remaining persistently while 14% were consistently without anti Tat IgG in the five blood sampling. No significant correlation was found between anti-Tat IgG and CD4+ T cell, CD8+ T cell and B cell counts revealing the incapacity of these anti Tat IgG to neutralize extra cellular Tat. Interestingly the absence and then the appearance of anti-Tat IgG in patients suggest the presence of HIV infected cells in the blood that may constitute a significant reservoir of HIV infected cells. As a conclusion antiretroviral therapy does not block the secretion of Tat and may explain why HIV infected cells can survive in spite of an effective ART treatment.


Antibody, antiretroviral therapy, b cell, HIV, Tat, vaccine, cellular immunity, HIV infected cells, anti Tat IgG, patients.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 12
Issue Number: 1
First Page: 81
Last Page: 86
Page Count: 6
DOI: 10.2174/187152612798994939

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science